Data / Federal rules / 2024-07473
Announcement of Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) inSchedule I
The Drug Enforcement Administration published this proposed rule in the Federal Register on April 9, 2024.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
This is notification that the Drug Enforcement Administration will hold a hearing with respect to the proposed placement of two phenethylamine hallucinogens, as identified in the proposed rule, in schedule I of the Controlled Substances Act.
Key facts
- Document number
- 2024-07473
- Type
- Proposed rule
- Action
- Notification of hearing on proposed rulemaking
- Agency
- Justice Department; Drug Enforcement Administration
- Published
- April 9, 2024
- Dates
- The hearing will commence on June 10, 2024, at 9 a.m. ET at the DEA Hearing Facility, 700 Army Navy Drive, Arlington, VA 22202. The hearing may be moved to a different place and may be continued from day to day or recessed to a later date without notice other than announcement thereof by the Administrative Law Judge at the hearing. 21 CFR 1316.53.
- Docket
- Docket No. DEA1156
- Code of Federal Regulations
- 21 CFR 1308
- Pages
- 2
Other documents from the Drug Enforcement Administration
Everything from the Drug Enforcement Administration · Published in April 2024
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.